Harbor Capital Advisors, Inc. Akouos, Inc. Transaction History

Harbor Capital Advisors, Inc.

  • $2.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 28, 2022
BUY
$2.6 - $5.16 $9,370 - $18,596
3,604 Added 4.46%
84,358 $570,000
Q2 2022

Jul 26, 2022
BUY
$2.46 - $5.2 $7,229 - $15,282
2,939 Added 3.78%
80,754 $379,000
Q1 2022

Apr 28, 2022
SELL
$4.16 - $9.08 $60,565 - $132,195
-14,559 Reduced 15.76%
77,815 $370,000
Q4 2021

Feb 04, 2022
BUY
$7.65 - $11.38 $706,661 - $1.05 Million
92,374 New
92,374 $785,000

About Akouos, Inc.

AKUS Quotes by TradingView
  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email